Detalhe da pesquisa
1.
GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
Semin Liver Dis
; 44(1): 99-114, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395061
2.
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
J Hepatol
; 63(3): 670-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908269
3.
Neurogenin3 cooperates with Foxa2 to autoactivate its own expression.
J Biol Chem
; 288(17): 11705-17, 2013 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23471965
4.
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma.
Cancers (Basel)
; 16(8)2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672578
5.
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
Front Immunol
; 15: 1400553, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817615
6.
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Biol Sex Differ
; 14(1): 85, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964320
7.
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances.
Cancers (Basel)
; 14(3)2022 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158892
8.
Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis.
J Hepatol
; 64(4): 983-4, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820628
9.
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species.
Antioxidants (Basel)
; 10(9)2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572967
10.
Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome.
Biomedicines
; 9(4)2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33810394
11.
Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis.
Cells
; 9(10)2020 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998369
12.
Mitochondrial Glutathione: Recent Insights and Role in Disease.
Antioxidants (Basel)
; 9(10)2020 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987701
13.
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models.
Cancers (Basel)
; 12(2)2020 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32024199
14.
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Cell Mol Gastroenterol Hepatol
; 9(3): 349-368, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31689560
15.
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.
Oncotarget
; 9(24): 16701-16717, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682179
16.
Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation.
Cell Death Dis
; 7(11): e2464, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27831566
17.
Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
Oncotarget
; 7(7): 8253-67, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26811497
18.
Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.
Sci Rep
; 5: 7916, 2015 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25604905